WATANABE Akihiko
No ORCID on file
· 102 papers in corpus
· active 2006-2007
Frequent coauthors
- KAWASAKI HIROKAZU 102
- OHSHIMA Etsuo 102
- KIMOTO NAOYA 85
- WATANABE AKIKO 17
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
2007
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.